Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Sejong Medical Co., Ltd. (258830:KRX), powered by AI.
Sejong Medical Co., Ltd. is currently trading at ₩412. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Sejong Medical Co., Ltd. on Alpha Lenz.
Sejong Medical Co., Ltd.'s P/E ratio is -1227.0.
“Sejong Medical Co., Ltd. trades at a P/E of -1227.0 (undervalued) with modest ROE of -0.1%.”
Ask for details →Sejong Medical Co., Ltd. is a medical technology company dedicated to the development, manufacturing, and distribution of innovative healthcare solutions. The company's primary focus lies in the production of medical devices that enhance surgical procedures and patient outcomes, particularly in the fields of minimally invasive surgery and oncology. Notable for its robust research and development capabilities, Sejong Medical Co., Ltd. is committed to advancing medical technology to meet the evolving needs of healthcare professionals and patients alike. Operating across various medical sectors, Sejong Medical’s products cater to an extensive range of healthcare facilities, including hospitals and surgical centers. By prioritizing quality and safety standards, the company ensures that its devices are both effective and reliable, cementing its position in the competitive medical device industry. In the financial market, Sejong Medical Co., Ltd. is recognized for its contribution to the healthcare sector, offering investors exposure to the growing demand for advanced medical technology and solutions. Its innovations have significant implications for improving surgical precision and patient care, highlighting its importance within the broader healthcare landscape.
“Sejong Medical Co., Ltd. trades at a P/E of -1227.0 (undervalued) with modest ROE of -0.1%.”
Ask for details →Sejong Medical Co., Ltd. (ticker: 258830) is a company listed on KRX in the Healthcare sector (Medical Instruments & Supplies). It has approximately 130 employees. Market cap is $31.2B.
The current price is ₩412 with a P/E ratio of -1,226.99x and P/B of 1.38x.
ROE is -0.12% and operating margin is 12.38%. Annual revenue is $18.5B.